Elevated plasma albumin and apolipoprotein A-I oxidation under suboptimal specimen storage conditions

Molecular and Cellular Proteomics

Volumn 13, Issue 7, 2014, Pages 1890-1899

  Borges, Chad R ^a,b   Rehder, Douglas S ^b   Jensen, Sally ^b   Schaab, Matthew R ^a   Sherma, Nisha D ^a   Yassine, Hussein ^c   Nikolova, Boriana ^d   Breburda, Christian ^d,e  

^a ARIZONA STATE UNIVERSITY   (United States)

^b Arizona State University   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Maricopa Integrated Health Systems   (United States)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; HUMAN SERUM ALBUMIN; METHIONINE; CYSTEINE; SERUM ALBUMIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANALYTIC METHOD; ARTICLE; BLOOD STORAGE; CLINICAL ARTICLE; DILUTE AND SHOOT METHOD; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FREEZE THAWING; HEALTH SURVEY; HUMAN; INFLAMMATION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEOMICS; ROOM TEMPERATURE; STORAGE TEMPERATURE; BLOOD; CHEMISTRY; CRYOPRESERVATION; FREEZING; HEART INFARCTION; METABOLISM; OXIDATION REDUCTION REACTION; PROCEDURES; PROSTATE TUMOR; SPECIMEN HANDLING;

APOLIPOPROTEIN A-I; CHROMATOGRAPHY, LIQUID; CRYOPRESERVATION; CYSTEINE; DIABETES MELLITUS, TYPE 2; FREEZING; HUMANS; MALE; METHIONINE; MYOCARDIAL INFARCTION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROSTATIC NEOPLASMS; SERUM ALBUMIN; SPECIMEN HANDLING; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84904121417     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.038455     Document Type: Article

References (47)

1. Peters, T. (1996) All About Albumin: Biochemistry, Genetics, and Medical Applications, Academic Press, San Diego
2. Anantharamaiah, G. M., Hughes, T. A., Iqbal, M., Gawish, A., Neame, P. J., Medley, M. F., and Segrest, J. P. (1988) Effect of oxidation on the properties of apolipoproteins A-I and A-II. J. Lipid Res. 29, 309-318
3. von Eckardstein, A., Walter, M., Holz, H., Benninghoven, A., and Assmann, G. (1991) Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III. J. Lipid Res. 32, 1465-1476
4. Panzenbock, U., Kritharides, L., Raftery, M., Rye, K. A., and Stocker, R. (2000) Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I. J. Biol. Chem. 275, 19536-19544 (Pubitemid 30441546)
5. Bar-Or, D., Heyborne, K. D., Bar-Or, R., Rael, L. T., Winkler, J. V., and Navot, D. (2005) Cysteinylation of maternal plasma albumin and its association with intrauterine growth restriction. Prenat. Diagn. 25, 245-249 (Pubitemid 40478012)
6. Pankhurst, G., Wang, X. L., Wilcken, D. E., Baernthaler, G., Panzenbock, U., Raftery, M., and Stocker, R. (2003) Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein. J. Lipid Res. 44, 349-355 (Pubitemid 37287778)
7. Panzenbock, U., and Stocker, R. (2005) Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins. Biochim. Biophys. Acta 1703, 171-181 (Pubitemid 40170440)
8. Wang, X. S., Shao, B., Oda, M. N., Heinecke, J. W., Mahler, S., and Stocker, R. (2009) A sensitive and specific ELISA detects methionine sulfoxidecontaining apolipoprotein A-I in HDL. J. Lipid Res. 50, 586-594
9. Borges, C. R., Oran, P. E., Buddi, S., Jarvis, J. W., Schaab, M. R., Rehder, D. S., Rogers, S. P., Taylor, T., and Nelson, R. W. (2011) Building multidimensional biomarker views of type 2 diabetes on the basis of protein microheterogeneity. Clin. Chem. 57, 719-728
10. Rael, L. T., Bar-Or, R., Ambruso, D. R., Mains, C. W., Slone, D. S., Craun, M. L., and Bar-Or, D. (2009) The effect of storage on the accumulation of oxidative biomarkers in donated packed red blood cells. J. Trauma 66, 76-81
11. Woodward, M., Croft, K. D., Mori, T. A., Headlam, H., Wang, X. S., Suarna, C., Raftery, M. J., MacMahon, S. W., and Stocker, R. (2009) Association between both lipid and protein oxidation and the risk of fatal or non-fatal coronary heart disease in a human population. Clin. Sci. 116, 53-60
12. Mullan, A., and Sattar, N. (2009) More knocks to the oxidation hypothesis for vascular disease? Clin. Sci. 116, 41-43
13. Lippi, G., Guidi, G. C., Mattiuzzi, C., and Plebani, M. (2006) Preanalytical variability: the dark side of the moon in laboratory testing. Clin. Chem. Lab. Med. 44, 358-365
14. Betsou, F., Barnes, R., Burke, T., Coppola, D., Desouza, Y., Eliason, J., Glazer, B., Horsfall, D., Kleeberger, C., Lehmann, S., Prasad, A., Skubitz, A., Somiari, S., and Gunter, E. (2009) Human biospecimen research: experimental protocol and quality control tools. Cancer Epidemiol. Biomarkers Prev. 18, 1017-1025
15. Moore, H. M., Compton, C. C., Lim, M. D., Vaught, J., Christiansen, K. N., and Alper, J. (2009) 2009 Biospecimen research network symposium: advancing cancer research through biospecimen science. Cancer Res. 69, 6770-6772
16. Betsou, F., Gunter, E., Clements, J., DeSouza, Y., Goddard, K. A., Guadagni, F., Yan, W., Skubitz, A., Somiari, S., Yeadon, T., and Chuaqui, R. (2013) Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group. J. Mol. Diagn. 15, 3-16
17. Rai, A. J., Gelfand, C. A., Haywood, B. C., Warunek, D. J., Yi, J. Z., Schuchard, M. D., Mehigh, R. J., Cockrill, S. L., Scott, G. B. I., Tammen, H., Schulz-Knappe, P., Speicher, D. W., Vitzthum, F., Haab, B. B., Siest, G., and Chan, D. W. (2005) HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5, 3262-3277 (Pubitemid 41192034)
18. Lim, M. D., Dickherber, A., and Compton, C. C. (2011) Before you analyze a human specimen, think quality, variability, and bias. Anal. Chem. 83, 8-13
19. Tuck, M. K., Chan, D. W., Chia, D., Godwin, A. K., Grizzle, W. E., Krueger, K. E., Rom, W., Sanda, M., Sorbara, L., Stass, S., Wang, W., and Brenner, D. E. (2009) Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J. Proteome Res. 8, 113-117
20. LaBaer, J. (2012) Improving international research with clinical specimens: 5 achievable objectives. J. Proteome Res. 11, 5592-5601
21. Rehder, D. S., and Borges, C. R. (2010) Cysteine sulfenic acid as an intermediate in disulfide bond formation and nonenzymatic protein folding. Biochemistry 49, 7748-7755
22. Turell, L., Botti, H., Carballal, S., Ferrer-Sueta, G., Souza, J. M., Duran, R., Freeman, B. A., Radi, R., and Alvarez, B. (2008) Reactivity of sulfenic acid in human serum albumin. Biochemistry 47, 358-367
23. Turell, L., Botti, H., Carballal, S., Radi, R., and Alvarez, B. (2009) Sulfenic acid - a key intermediate in albumin thiol oxidation. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 3384-3392
24. Turell, L., Carballal, S., Botti, H., Radi, R., and Alvarez, B. (2009) Oxidation of the albumin thiol to sulfenic acid and its implications in the intravascular compartment. Braz. J. Med. Biol. Res. 42, 305-311
25. Linde, S., Nielsen, J. H., Hansen, B., and Welinder, B. S. (1990) High-performance liquid chromatography of rat and mouse islet polypeptides: potential risk of oxidation of methionine residues during sample preparation. J. Chromatogr. 530, 29-37 (Pubitemid 20256486)
26. Brot, N., and Weissbach, H. (1991) Biochemistry of methionine sulfoxide residues in proteins. BioFactors 3, 91-96
27. Farrugia, A., Hill, R., Douglas, S., Karabagias, K., and Kleinig, A. (1992) Factor VIII/von Willebrand factor levels in plasma frozen to -30 degrees C in air or halogenated hydrocarbons. Thromb. Res. 68, 97-102
28. MacKenzie, A. P. (1980) First and second order transitions during the freezing and thawing of source plasma (human). American Institute of Chemical Engineers (New York) Symposium on Processing and Fractionation of Blood Plasma, Philadelphia, June 8-12
29. Bravo, M. I., Grancha, S., and Jorquera, J. I. (2006) Effect of temperature on plasma freezing under industrial conditions. Pharmeur. Sci. Notes 2006, 31-35
30. (2005) Human Plasma for Fractionation, Monograph 0853, Council of Europe, Strasbourg, France
31. The Early Detection Research Network (EDRN) Standard Operating Procedure (SOP) for Collection of EDTA Plasma
32. The Early Detection Research Network (EDRN) Standard Operating Procedure (SOP) for Collection of Serum
33. Boys, B. L., Kuprowski, M. C., Noel, J. J., and Konermann, L. (2009) Protein oxidative modifications during electrospray ionization: solution phase electrochemistry or corona discharge-induced radical attack? Anal. Chem. 81, 4027-4034
34. Yassine, H., Borges, C. R., Schaab, M. R., Billheimer, D., Stump, C., Reaven, P., Lau, S. S., and Nelson, R. (2013) Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes. Proteomics Clin. Applicat. 7, 528-540
35. Bar-Or, D., Bar-Or, R., Rael, L. T., Gardner, D. K., Slone, D. S., and Craun, M. L. (2005) Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit. Care Med. 33, 1638-1641 (Pubitemid 40980625)
36. Rehder, D., Schaab, M., and Borges, C. (2014) Buffers for stabilizing biological specimens and their use. U.S. Patent 8,669,111
37. Park, Y., Ziegler, T. R., Gletsu-Miller, N., Liang, Y., Yu, T., Accardi, C. J., and Jones, D. P. (2010) Postprandial cysteine/cystine redox potential in human plasma varies with meal content of sulfur amino acids. J. Nutr. 140, 760-765
38. Moriarty, S. E., Shah, J. H., Lynn, M., Jiang, S., Openo, K., Jones, D. P., and Sternberg, P. (2003) Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic. Biol. Med. 35, 1582-1588 (Pubitemid 37532909)
39. Centers for Disease Control and Prevention and National Center for Health Statistics. (2006) National Health and Nutrition Examination Survey Data. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, MD
40. Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., and Mao, S. J. T. (1983) Apolipoprotein-a-I as a marker of angiographically assessed coronary-artery disease. N. Engl. J. Med. 309, 385-389 (Pubitemid 13033962)
41. Garner, B., Witting, P. K., Waldeck, A. R., Christison, J. K., Raftery, M., and Stocker, R. (1998) Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol. J. Biol. Chem. 273, 6080-6087 (Pubitemid 28144687)
42. Garner, B., Waldeck, A. R., Witting, P. K., Rye, K. A., and Stocker, R. (1998) Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J. Biol. Chem. 273, 6088-6095 (Pubitemid 28144688)
43. Bowry, V. W., Stanley, K. K., and Stocker, R. (1992) High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl. Acad. Sci. U.S.A. 89, 10316-10320
44. Sattler, W., Christison, J., and Stocker, R. (1995) Cholesterylester hydroperoxide reducing activity associated with isolated high- and low-density lipoproteins. Free Radic. Biol. Med. 18, 421-429
45. Mashima, R., Yamamoto, Y., and Yoshimura, S. (1998) Reduction of phosphatidylcholine hydroperoxide by apolipoprotein A-I: purification of the hydroperoxide-reducing proteins from human blood plasma. J. Lipid Res. 39, 1133-1140 (Pubitemid 28270076)
46. Wu, Z., Wagner, M. A., Zheng, L., Parks, J. S., Shy, J. M., 3rd, Smith, J. D., Gogonea, V., and Hazen, S. L. (2007) The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction. Nat. Struct. Mol. Biol. 14, 861-868 (Pubitemid 47373831)
47. Segrest, J. P., Jones, M. K., Klon, A. E., Sheldahl, C. J., Hellinger, M., De Loof, H., and Harvey, S. C. (1999) A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. J. Biol. Chem. 274, 31755-31758